NASDAQ:JAZZ

Jazz Pharmaceuticals - JAZZ News Today

$144.68

+1.27 (+0.89%)

(As of 03/30/2023 01:08 PM ET)

Add

Compare

Today's Range: $143.91
▼
$145.29
50-Day Range: $133.98
▼
$157.77
52-Week Range: $125.36
▼
$169.98

Volume: 190,209 shs
Average Volume: 526,582 shs
Market Capitalization: $9.16 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $204.27

Institutional Ownership

Get Jazz Pharmaceuticals News Delivered to You Automatically

JAZZ Media Mentions By Week

JAZZ Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JAZZ
News Sentiment
▼
0.93

0.61
▲
Average
Medical
News Sentiment

JAZZ News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JAZZ Articles
This Week
▼
12

5
▲
JAZZ Articles
Average Week

Source

Source	Headline
	State of Alaska Department of Revenue Cuts Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) marketbeat.com - March 28 at 4:36 AM
	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Rating of "Moderate Buy" by Analysts marketbeat.com - March 25 at 2:48 AM
	Zymeworks Offers Hope for More than Just Long-Term Investors (JAZZ) marketbeat.com - March 9 at 6:45 AM
	Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million finanznachrichten.de - March 30 at 8:16 AM
	Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results finanznachrichten.de - March 30 at 8:16 AM
	Jazz Pharmaceuticals Expands Support of the American Heart Association to Raise Awareness of the Link Between Sleep Disorders and Heart Health finance.yahoo.com - March 30 at 8:16 AM
	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives Consensus Recommendation of "Moderate Buy" from Analysts americanbankingnews.com - March 30 at 5:46 AM
	Medical Asparaginase Market Share, Key Dynamics and Forecast to 2031 marketwatch.com - March 28 at 10:10 AM
	More than 100 Biopharmas Increase Impactful Engagement with Veeva CRM Events Management markets.businessinsider.com - March 28 at 10:10 AM
	Lewy Body Dementia Treatment Market Top Players By 2031 marketwatch.com - March 28 at 12:00 AM
	Oligonucleotide Therapeutics Market \| Newsest Research marketwatch.com - March 27 at 8:58 AM
	Asparaginase Market Growth and Forecast till 2031 marketwatch.com - March 23 at 12:48 PM
	Global Asparaginase Market (2023-2029)-Opportunities for Growth and Expansion marketwatch.com - March 22 at 3:47 PM
	My Top Cannabis Stock to Buy in 2023 and Hold For 10 Years finance.yahoo.com - March 21 at 8:53 AM
	Clozapine Market Share and Forecast till 2028 marketwatch.com - March 17 at 4:13 AM
	RBC Capital Keeps Their Buy Rating on Nuvation Bio (NUVB) markets.businessinsider.com - March 16 at 4:36 PM
	Jazz Pharmaceuticals to Present Data at 2023 AACR Annual Meeting Showcasing New Zepzelca® (lurbinectedin) Data and Expanded Oncology Pre-Clinical and Clinical Pipeline finance.yahoo.com - March 15 at 7:34 AM
	Celadon becomes first UK medical cannabis group to win right to sell in Britain ft.com - March 14 at 4:32 PM
	Marine Pharmaceuticals Market Analysis: Understanding The Current State and Future Trends 2023-2028 marketwatch.com - March 14 at 10:07 AM
	Bank of America Securities Keeps Their Buy Rating on Jazz Pharmaceuticals (JAZZ) markets.businessinsider.com - March 14 at 10:07 AM
	Jazz Pharmaceuticals Secures Eight Additional Provincial Reimbursements for Vyxeos® for Treatment of Adults with Newly Diagnosed Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes finance.yahoo.com - March 8 at 1:40 PM
	Those who invested in Jazz Pharmaceuticals (NASDAQ:JAZZ) three years ago are up 29% finance.yahoo.com - March 8 at 7:06 AM
	RBC Capital Reaffirms Their Buy Rating on Verrica Pharmaceuticals (VRCA) markets.businessinsider.com - March 7 at 4:05 PM
	The Latest Analyst Ratings for Jazz Pharmaceuticals msn.com - March 6 at 7:51 PM
	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2022 Earnings Call Transcript finance.yahoo.com - March 6 at 2:45 AM
	Jazz Q4 2022 Revenue Grows 8% To $972M, Provides Outlook msn.com - March 2 at 2:25 PM
	Jazz Pharmaceuticals (JAZZ) Reports Q4 Loss, Misses Revenue Estimates finance.yahoo.com - March 1 at 11:08 PM
	Jazz Pharmaceuticals Non-GAAP EPS of -$0.07 misses by $1.19, revenue of $972.12M misses by $3.75M, guidance in-line msn.com - March 1 at 6:08 PM
	Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance finance.yahoo.com - March 1 at 6:08 PM
	Is Jazz Pharmaceuticals 'All That' Heading Into Earnings? finance.yahoo.com - March 1 at 1:07 PM
	Axsome (AXSM) Q4 Earnings Miss, Auvelity Records First Sales nasdaq.com - February 28 at 10:55 PM
	Earnings Preview For Jazz Pharmaceuticals msn.com - February 28 at 10:55 PM
	Drug Company Exploits a Safety Requirement to Make Money finance.yahoo.com - February 28 at 10:17 AM
	Medical Asparaginase Market to Grow Significantly by Leading Players 2023 to 2028 marketwatch.com - February 28 at 5:16 AM
	A Drug Company Exploited a Safety Requirement to Make Money nytimes.com - February 28 at 5:16 AM
	Jazz Pharmaceuticals: Challenges To Repricing seekingalpha.com - February 25 at 5:13 PM
	Pharmas, medtechs dominate list of innovation leaders thanks to patents seekingalpha.com - February 25 at 5:13 PM
	Analysis of Kidrolase Market 2023: Growth Opportunities and Industry Trends by 2029 marketwatch.com - February 22 at 5:46 PM
	Axsome in licensing pact with Pharmanovia for sleep disorder therapy Sunosi msn.com - February 22 at 8:44 AM
	The Rise of Medical Asparaginase Market Research 2023-2027: Opportunities and Challenges with Top Countries Data marketwatch.com - February 21 at 7:33 AM
	Advancement in Oligonucleotide Therapeutics Market with Respect to Upcoming Challenges by 2026 marketwatch.com - February 21 at 7:33 AM
	Non Cataplexy Narcolepsy Drugs Market to Eyewitness Massive Growth 2023 to 2028 marketwatch.com - February 20 at 10:07 AM
	First Week of April 21st Options Trading For Jazz Pharmaceuticals nasdaq.com - February 19 at 10:42 PM
	Cannabis-Based Medicine As A Potential Treatment For Psychosis, An Oxford University Study Says msn.com - February 17 at 6:52 PM
	Narcolepsy Treatment Drug Market 2023 Assessed to See Remarkable Growth till 2028 \| Says Absolute Reports Experts marketwatch.com - February 16 at 7:46 PM
	Jazz Pharmaceuticals to Report 2022 Fourth Quarter and Full Year Financial Results on March 1, 2023 finance.yahoo.com - February 15 at 6:47 PM
	Oligonucleotide Therapy Global Market Report 2023 finance.yahoo.com - February 13 at 5:33 PM
	Narcolepsy Therapeutics Market In 2023 By In-depth Analysis of Revenue Forecast and Competitive Landscape 2028 marketwatch.com - February 13 at 7:32 AM
	Hypercytokinemia Market is anticipated to boost sales at a Impressive CAGR marketwatch.com - February 10 at 8:27 AM
	Oligonucleotide Therapeutics Market 2023 Will See a Massive Rise in Revenues of 9290.6 Million by 2027 With 16.7% CAGR\| 100 Pages Report marketwatch.com - February 8 at 8:46 PM
	Biosimilar Growth Hormones Global Market Report 2023 uk.finance.yahoo.com - February 8 at 3:45 PM
	Asparaginase Market 2023 to 2029 by Key Players Jazz Pharmaceuticals, Servier Pharmaceuticals, Medac GmbH, Kyowa Hakko Kirin marketwatch.com - February 7 at 1:18 PM
	Uncovering Hidden Opportunities in the Sleep-Wake Disorder Market (2023-2028) marketwatch.com - February 7 at 7:43 AM

Get Jazz Pharmaceuticals News Delivered to You Automatically

This page (NASDAQ:JAZZ) was last updated on 3/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Jazz Pharmaceuticals - JAZZ News Today

JAZZ Media Mentions By Week

JAZZ Media Sentiment

JAZZ News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info